Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Osteogenic activity of yellow flag iris (Iris pseudacorus) extract modulating differentiation of osteoblasts and osteoclasts.

Kim JL, Li HM, Kim YH, Lee YJ, Shim JH, Lim SS, Kang YH.

Am J Chin Med. 2012;40(6):1289-305. doi: 10.1142/S0192415X12500954.

PMID:
23227798
2.

Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.

Kim JL, Kang SW, Kang MK, Gong JH, Lee ES, Han SJ, Kang YH.

J Cell Biochem. 2012 Jan;113(1):247-59. doi: 10.1002/jcb.23351.

PMID:
21898547
3.

Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption.

Jun AY, Kim HJ, Park KK, Son KH, Lee DH, Woo MH, Kim YS, Lee SK, Chung WY.

Fitoterapia. 2012 Dec;83(8):1523-31. doi: 10.1016/j.fitote.2012.08.020. Epub 2012 Sep 5.

PMID:
22981503
4.
5.
7.

Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.

Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.

Int Immunopharmacol. 2007 Dec 5;7(12):1507-16. Epub 2007 Aug 8.

PMID:
17920527
8.

Regulation of the differentiation of osteoblasts and osteoclasts by a hot-water extract of adzuki beans (Vigna angularis).

Itoh T, Nakamura M, Nakamichi H, Ando M, Tsukamasa Y, Furuichi Y.

Biosci Biotechnol Biochem. 2014;78(1):92-9. doi: 10.1080/09168451.2014.877182. Epub 2014 Apr 10.

PMID:
25036490
9.
10.

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.

Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, Jia CH, Wen ZH, Jin DD, Bai XC.

J Cell Biochem. 2011 Oct;112(10):2902-9. doi: 10.1002/jcb.23206.

PMID:
21618594
11.

Toddaculin, Isolated from of Toddalia asiatica (L.) Lam., Inhibited Osteoclastogenesis in RAW 264 Cells and Enhanced Osteoblastogenesis in MC3T3-E1 Cells.

Watanabe A, Kumagai M, Mishima T, Ito J, Otoki Y, Harada T, Kato T, Yoshida M, Suzuki M, Yoshida I, Fujita K, Watai M, Nakagawa K, Miyazawa T.

PLoS One. 2015 May 18;10(5):e0127158. doi: 10.1371/journal.pone.0127158. eCollection 2015.

12.

Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation.

Kamiya S, Nakamura C, Fukawa T, Ono K, Ohwaki T, Yoshimoto T, Wada S.

J Bone Miner Metab. 2007;25(5):277-85. Epub 2007 Aug 25.

PMID:
17704992
13.

Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells.

Satué M, Arriero Mdel M, Monjo M, Ramis JM.

Biochem Pharmacol. 2013 Nov 15;86(10):1476-86. doi: 10.1016/j.bcp.2013.09.009. Epub 2013 Sep 20.

PMID:
24060614
14.

Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.

Wang X, Wu J, Shidoji Y, Muto Y, Ohishi N, Yagi K, Ikegami S, Shinki T, Udagawa N, Suda T, Ishimi Y.

J Bone Miner Res. 2002 Jan;17(1):91-100.

15.

Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.

Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.

Life Sci. 2007 Mar 13;80(14):1311-8. Epub 2007 Jan 23.

PMID:
17306833
16.

Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation.

Uchino K, Okamoto K, Sakai E, Yoneshima E, Iwatake M, Fukuma Y, Nishishita K, Tsukuba T.

Phytother Res. 2015 Nov;29(11):1714-21. doi: 10.1002/ptr.5416. Epub 2015 Jul 14.

PMID:
26172226
17.

Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Lee JW, Iwahashi A, Hasegawa S, Yonezawa T, Jeon WB, Cha BY, Nagai K, Woo JT.

J Nat Med. 2012 Jan;66(1):8-16. doi: 10.1007/s11418-011-0537-7. Epub 2011 Jun 9.

PMID:
21656335
18.

Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.

Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kobayashi Y, Nakamura H, Takahashi N, Udagawa N.

J Bone Miner Res. 2009 Aug;24(8):1469-80. doi: 10.1359/jbmr.090302.

19.

Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption.

Ren ZY, Machuca-Gayet I, Domenget C, Buchet R, Wu Y, Jurdic P, Mebarek S.

PLoS One. 2015 Jul 13;10(7):e0132513. doi: 10.1371/journal.pone.0132513. eCollection 2015.

20.

The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.

Idris AI, Landao-Bassonga E, Ralston SH.

Bone. 2010 Apr;46(4):1089-99. doi: 10.1016/j.bone.2010.01.368. Epub 2010 Jan 22.

PMID:
20096813

Supplemental Content

Support Center